GLUE
Monte Rosa Therapeutics, Inc.
Company overview
- Market capitalization
- $999.02M
- Employees
- 187
- Latest publication
- 2026-09-29
About Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1a, IL-1ß and IL-18, as well as damage-associated molecular patterns. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd.; and Novartis. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q4 20232023-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,968,000USD | 2,781,000USD | 12,768,000USD | 23,194,000USD | 84,929,000USD | 60,647,000USD | 9,216,000USD | 8,752,000USD |
| Research Development | 47,964,000USD | 41,979,000USD | 36,678,000USD | 30,653,000USD | 32,190,000USD | 38,866,000USD | 27,616,000USD | 27,135,000USD |
| General And Administrative Expenses | 10,134,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 58,098,000USD | 52,496,000USD | 45,743,000USD | 38,748,000USD | 40,893,000USD | 47,643,000USD | 35,743,000USD | 34,863,000USD |
| Operating Income | -49,130,000USD | -49,715,000USD | -32,975,000USD | -15,554,000USD | 44,036,000USD | 13,004,000USD | -26,527,000USD | -34,863,000USD |
| Total Other Income Expense Net | 5,941,000USD | 3,639,000USD | 2,717,000USD | 4,458,000USD | 3,671,000USD | 2,597,000USD | 2,739,000USD | 1,589,000USD |
| Income Before Tax | -43,189,000USD | -46,076,000USD | -30,258,000USD | -11,096,000USD | 47,707,000USD | 15,601,000USD | -23,788,000USD | -33,274,000USD |
| Income Tax Expense | 208,000USD | 59,000USD | -3,177,000USD | 1,199,000USD | 822,000USD | 2,164,000USD | 71,000USD | -22,000USD |
| Net Income | -43,397,000USD | -46,135,000USD | -27,081,000USD | -12,295,000USD | 46,885,000USD | 13,437,000USD | -23,859,000USD | -33,252,000USD |
| Cost Of Revenue | — | 2,088,000USD | 2,095,000USD | 2,125,000USD | — | 2,061,000USD | 2,103,000USD | 1,846,000USD |
| Gross Profit | — | 2,781,000USD | 12,768,000USD | 23,194,000USD | 84,929,000USD | 60,647,000USD | 9,216,000USD | -1,846,000USD |
| Selling General Administrative | — | 10,517,000USD | 9,065,000USD | 8,095,000USD | 8,703,000USD | 8,777,000USD | 8,127,000USD | 7,728,000USD |
| Interest Income | — | 3,689,000USD | 2,746,000USD | 3,068,000USD | 3,439,000USD | 2,595,000USD | 2,892,000USD | 2,368,000USD |
| Net Interest Income | — | 3,689,000USD | 2,746,000USD | 3,068,000USD | 3,439,000USD | 2,595,000USD | 2,892,000USD | 2,368,000USD |
| Tax Provision | — | 59,000USD | -3,177,000USD | 1,199,000USD | 822,000USD | 2,164,000USD | 71,000USD | -22,000USD |
| Net Income From Continuing Ops | — | -46,135,000USD | -27,081,000USD | -12,295,000USD | 46,885,000USD | 13,437,000USD | -23,859,000USD | -33,252,000USD |
| Ebit | — | -46,076,000USD | -30,258,000USD | -11,096,000USD | 47,707,000USD | 15,601,000USD | -23,788,000USD | -33,274,000USD |
| Ebitda | — | -43,988,000USD | -28,163,000USD | -8,971,000USD | 49,755,000USD | 17,662,000USD | -21,685,000USD | -31,428,000USD |
| Depreciation And Amortization | — | 2,088,000USD | 2,095,000USD | 2,125,000USD | 2,048,000USD | 2,061,000USD | 2,103,000USD | 1,846,000USD |
| Reconciled Depreciation | — | 2,088,000USD | 2,095,000USD | 2,125,000USD | 2,048,000USD | 2,061,000USD | 2,103,000USD | 1,846,000USD |
| Interest Expense | — | — | — | — | — | — | — | 935,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD |
| Cost Of Revenue | 6,222,000USD | 537,000USD | 72,000USD |
| Gross Profit | -6,222,000USD | -537,000USD | -72,000USD |
| Research Development | 105,050,000USD | 23,468,000USD | 7,350,000USD |
| Selling General Administrative | 32,039,000USD | 4,005,000USD | 644,000USD |
| Total Operating Expenses | 137,089,000USD | 27,473,000USD | 7,994,000USD |
| Operating Income | -143,311,000USD | -28,010,000USD | -7,994,000USD |
| Interest Income | 8,956,000USD | 9,000USD | — |
| Net Interest Income | 8,956,000USD | 9,000USD | -1,000USD |
| Income Before Tax | -135,014,000USD | -35,879,000USD | -7,740,000USD |
| Income Tax Expense | 338,000USD | 189,000USD | 277,000USD |
| Tax Provision | 338,000USD | — | — |
| Net Income | -135,352,000USD | -35,879,000USD | -8,017,000USD |
| Net Income From Continuing Ops | -132,882,000USD | -35,879,000USD | -7,740,000USD |
| Ebit | -135,014,000USD | -28,010,000USD | -7,739,000USD |
| Ebitda | -128,792,000USD | -27,473,000USD | -7,667,000USD |
| Depreciation And Amortization | 6,222,000USD | 537,000USD | 72,000USD |
| Reconciled Depreciation | 5,446,000USD | 537,000USD | 72,000USD |
| Total Other Income Expense Net | 8,297,000USD | -7,869,000USD | 254,000USD |
| Interest Expense | — | 9,000USD | 1,000USD |
| Net Income Applicable To Common Shares | — | -35,879,000USD | -92,880,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 691,161,000USD | 736,428,000USD | 448,659,000USD | 459,841,000USD | 359,586,000USD | 393,199,000USD | 438,732,000USD | 315,080,000USD |
| Cash And Equivalents | 90,104,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 631,406,000USD | 677,547,000USD | 393,185,000USD | 401,817,000USD | 299,465,000USD | 332,280,000USD | 377,440,000USD | 251,207,000USD |
| Other Current Assets | 5,382,000USD | 6,718,000USD | 11,481,000USD | 5,594,000USD | 6,501,000USD | 4,798,000USD | 5,118,000USD | 8,426,000USD |
| Other Non Current Assets | 828,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 203,880,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 59,658,000USD | 71,036,000USD | 64,212,000USD | 61,443,000USD | 41,852,000USD | 59,216,000USD | 156,946,000USD | 41,641,000USD |
| Total Stockholder Equity | 487,281,000USD | 521,916,000USD | 233,056,000USD | 245,837,000USD | 268,080,000USD | 275,160,000USD | 222,936,000USD | 205,457,000USD |
| Total Equity Including Noncontrolling Interest | 487,281,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 22,103,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 53,988,000USD | 53,102,000USD | 50,372,000USD | 52,663,000USD | 54,726,000USD | 55,599,000USD | 56,314,000USD | 58,806,000USD |
| Accounts Payable | 7,152,000USD | 7,900,000USD | 3,550,000USD | 14,509,000USD | 5,581,000USD | 6,489,000USD | 17,215,000USD | 3,978,000USD |
| Short Term Debt | 4,630,000USD | 4,483,000USD | 4,397,000USD | 4,241,000USD | 4,094,000USD | 3,865,000USD | 3,714,000USD | 3,646,000USD |
| Common Stock | 9,000USD | 8,000USD | 7,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -565,114,000USD | -521,717,000USD | -477,214,000USD | -431,079,000USD | -403,998,000USD | -391,703,000USD | -438,588,000USD | -452,025,000USD |
| Accumulated Other Comprehensive Income | -5,165,000USD | -4,746,000USD | -3,827,000USD | -3,247,000USD | -3,373,000USD | -3,329,000USD | -3,356,000USD | -2,322,000USD |
| Total Liab | — | 214,512,000USD | 215,603,000USD | 214,004,000USD | 91,506,000USD | 118,039,000USD | 215,796,000USD | 109,623,000USD |
| Other Current Liab | — | 25,594,000USD | 26,694,000USD | 17,902,000USD | 13,767,000USD | 16,287,000USD | 18,785,000USD | 15,099,000USD |
| Capital Stock | — | 8,000USD | 7,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Cash | — | 159,859,000USD | 129,883,000USD | 208,343,000USD | 69,429,000USD | 78,530,000USD | 224,254,000USD | 125,575,000USD |
| Cash And Short Term Investments | — | 666,220,000USD | 377,104,000USD | 391,258,000USD | 290,594,000USD | 326,074,000USD | 372,149,000USD | 242,186,000USD |
| Current Deferred Revenue | — | 33,059,000USD | 29,571,000USD | 24,791,000USD | 18,410,000USD | 32,575,000USD | 117,232,000USD | 18,918,000USD |
| Net Debt | — | -120,795,000USD | -90,692,000USD | -168,175,000USD | -28,298,000USD | -36,666,000USD | -181,539,000USD | -81,877,000USD |
| Short Long Term Debt Total | — | 39,064,000USD | 39,191,000USD | 40,168,000USD | 41,131,000USD | 41,864,000USD | 42,715,000USD | 43,698,000USD |
| Short Term Investments | — | 506,361,000USD | 247,221,000USD | 182,915,000USD | 221,165,000USD | 247,544,000USD | 147,895,000USD | 116,611,000USD |
| Net Receivables | — | 4,609,000USD | 4,600,000USD | 4,965,000USD | 2,370,000USD | 1,408,000USD | 173,000USD | 595,000USD |
| Property Plant Equipment Gross | — | 82,746,000USD | 77,985,000USD | 78,187,000USD | 78,155,000USD | 76,904,000USD | 76,678,000USD | 77,110,000USD |
| Common Stock Shares Outstanding | — | 65,543,723shares | 65,543,723shares | 82,397,753shares | 82,186,768shares | 82,956,423shares | 61,436,740shares | 82,011,670shares |
| Non Current Assets Total | — | 58,881,000USD | 55,474,000USD | 58,024,000USD | 60,121,000USD | 60,919,000USD | 61,292,000USD | 63,873,000USD |
| Non Current Liabilities Total | — | 143,476,000USD | 151,391,000USD | 152,561,000USD | 49,654,000USD | 58,823,000USD | 58,850,000USD | 67,982,000USD |
| Non Currrent Assets Other | — | 5,779,000USD | 5,102,000USD | 5,361,000USD | 445,000USD | 5,320,000USD | 4,978,000USD | 159,000USD |
| Net Working Capital | — | 606,511,000USD | 328,973,000USD | 340,374,000USD | 257,613,000USD | 273,064,000USD | 220,494,000USD | 209,566,000USD |
| Unclassified Non Current Liabilities | — | 143,476,000USD | 151,391,000USD | 152,561,000USD | 49,654,000USD | 58,823,000USD | 58,850,000USD | 67,982,000USD |
| Unclassified Equity | — | 1,048,363,000USD | 714,083,000USD | 680,151,000USD | 675,439,000USD | 670,180,000USD | 664,868,000USD | 659,792,000USD |
| Unclassified Non Current Assets | — | — | — | — | 4,950,000USD | — | — | 4,908,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 448,659,000USD | 438,732,000USD | 303,755,000USD | 342,389,000USD | 366,329,000USD | 49,378,000USD | 11,094,000USD |
| Other Current Assets | 11,481,000USD | 5,118,000USD | 3,294,000USD | 5,404,000USD | 2,595,000USD | 1,892,000USD | 3,764,000USD |
| Total Liab | 215,603,000USD | 215,796,000USD | 124,505,000USD | 70,976,000USD | 18,814,000USD | 98,106,000USD | 23,242,000USD |
| Total Stockholder Equity | 233,056,000USD | 222,936,000USD | 179,250,000USD | 271,413,000USD | 347,515,000USD | -48,728,000USD | -12,148,000USD |
| Other Current Liab | 26,694,000USD | 18,785,000USD | 14,600,000USD | 14,580,000USD | 10,080,000USD | 22,209,000USD | 347,000USD |
| Common Stock | 7,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 1,000USD | 50,000USD |
| Capital Stock | 7,000USD | 6,000USD | 5,000USD | 5,000USD | 5,000USD | 1,000USD | 50,000USD |
| Retained Earnings | -477,214,000USD | -438,588,000USD | -365,888,000USD | -230,536,000USD | -122,035,000USD | -48,077,000USD | -12,198,000USD |
| Cash | 129,883,000USD | 224,254,000USD | 128,101,000USD | 54,912,000USD | 346,071,000USD | 41,699,000USD | 5,995,000USD |
| Cash And Short Term Investments | 377,104,000USD | 372,149,000USD | 232,413,000USD | 262,826,000USD | 346,071,000USD | 41,699,000USD | 5,995,000USD |
| Total Current Assets | 393,185,000USD | 377,440,000USD | 236,212,000USD | 275,886,000USD | 348,666,000USD | 43,591,000USD | 9,759,000USD |
| Total Current Liabilities | 64,212,000USD | 156,946,000USD | 46,592,000USD | 25,569,000USD | 16,638,000USD | 29,275,000USD | 4,292,000USD |
| Current Deferred Revenue | 29,571,000USD | 117,232,000USD | 17,678,000USD | — | — | — | — |
| Net Debt | -90,692,000USD | -181,539,000USD | -82,062,000USD | -7,911,000USD | -346,071,000USD | 26,065,000USD | -5,245,000USD |
| Short Term Debt | 4,397,000USD | 3,714,000USD | 3,162,000USD | 3,127,000USD | — | — | 750,000USD |
| Short Long Term Debt Total | 39,191,000USD | 42,715,000USD | 46,039,000USD | 47,001,000USD | — | 67,764,000USD | 750,000USD |
| Short Term Investments | 247,221,000USD | 147,895,000USD | 104,312,000USD | 207,914,000USD | 0USD | — | — |
| Net Receivables | 4,600,000USD | 173,000USD | 505,000USD | 7,656,000USD | — | 79,000USD | 51,000USD |
| Accounts Payable | 3,550,000USD | 17,215,000USD | 11,152,000USD | 7,862,000USD | 6,558,000USD | 7,066,000USD | 3,195,000USD |
| Property Plant Equipment Net | 50,372,000USD | 56,314,000USD | 62,611,000USD | 61,907,000USD | 12,325,000USD | 4,623,000USD | 1,335,000USD |
| Property Plant Equipment Gross | 77,985,000USD | 76,678,000USD | 74,855,000USD | 61,907,000USD | 15,028,000USD | 4,623,000USD | 1,335,000USD |
| Accumulated Other Comprehensive Income | -3,827,000USD | -3,356,000USD | -2,724,000USD | -1,752,000USD | -2,021,000USD | -1,056,000USD | -68,950USD |
| Common Stock Shares Outstanding | 83,071,185shares | 73,910,026shares | 51,396,961shares | 47,227,370shares | 46,535,966shares | 44,002,715shares | 44,002,715shares |
| Non Current Assets Total | 55,474,000USD | 61,292,000USD | 67,543,000USD | 66,503,000USD | 17,663,000USD | 5,787,000USD | 1,335,000USD |
| Non Current Liabilities Total | 151,391,000USD | 58,850,000USD | 77,913,000USD | 45,407,000USD | 2,176,000USD | 68,831,000USD | 18,950,000USD |
| Non Currrent Assets Other | 5,102,000USD | 4,978,000USD | 4,932,000USD | 4,596,000USD | 5,338,000USD | 1,164,000USD | — |
| Net Working Capital | 328,973,000USD | 220,494,000USD | 189,620,000USD | 250,317,000USD | 332,028,000USD | 14,316,000USD | 5,467,000USD |
| Unclassified Non Current Liabilities | 151,391,000USD | 58,850,000USD | 77,913,000USD | -1,533,000USD | -2,176,000USD | 67,764,000USD | 18,950,000USD |
| Unclassified Equity | 714,083,000USD | 664,868,000USD | 547,852,000USD | 503,691,000USD | 471,561,000USD | — | — |
| Other Liab | — | — | — | 1,533,000USD | 2,176,000USD | 1,067,000USD | — |
| Other Assets | — | — | — | 4,596,000USD | 5,338,000USD | 1,164,000USD | — |
| Inventory | — | — | — | 960,000USD | — | — | — |
| Non Current Liabilities Other | — | — | — | 45,407,000USD | 2,176,000USD | — | — |
| Net Tangible Assets | — | — | — | 271,413,000USD | 347,515,000USD | -48,728,000USD | -12,148,000USD |
| Unclassified Non Current Assets | — | — | — | -4,596,000USD | -5,338,000USD | -1,164,000USD | — |
| Short Long Term Debt | — | — | — | — | — | — | 750,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -44,503,000USD | -46,135,000USD | -27,081,000USD | -12,295,000USD | 46,885,000USD | 13,437,000USD | -23,859,000USD | -30,310,000USD |
| Depreciation | 2,029,000USD | 2,088,000USD | 2,095,000USD | 2,125,000USD | 2,048,000USD | 2,061,000USD | 2,103,000USD | 2,060,000USD |
| Stock Based Compensation | 5,949,000USD | 4,309,000USD | 4,364,000USD | 4,894,000USD | 5,298,000USD | 4,469,000USD | 4,282,000USD | 4,502,000USD |
| Other Non Cash Items | -985,000USD | 87,000USD | -466,000USD | -737,000USD | -1,088,000USD | -696,000USD | -1,089,000USD | -1,094,000USD |
| Change To Account Receivables | 6,991,000USD | -2,208,000USD | -2,596,000USD | -961,000USD | -1,235,000USD | 422,000USD | 9,247,000USD | -9,327,000USD |
| Change In Working Capital | 141,000USD | -3,363,000USD | 121,516,000USD | -28,707,000USD | -98,635,000USD | 109,651,000USD | -2,431,000USD | -2,925,000USD |
| Total Cash From Operating Activities | -37,369,000USD | -43,014,000USD | 100,428,000USD | -34,720,000USD | -45,492,000USD | 128,922,000USD | -20,994,000USD | -27,767,000USD |
| Capital Expenditures | -1,868,000USD | -767,000USD | -651,000USD | -1,695,000USD | -1,587,000USD | -183,000USD | -399,000USD | -2,022,000USD |
| Free Cash Flow | -39,237,000USD | -43,781,000USD | 99,777,000USD | -36,415,000USD | -47,079,000USD | 128,739,000USD | -21,393,000USD | -29,789,000USD |
| Investments | -259,129,000USD | -64,299,000USD | 38,138,000USD | 25,324,000USD | -100,229,000USD | -30,896,000USD | 37,749,000USD | -61,158,000USD |
| Total Cashflows From Investing Activities | -260,997,000USD | -65,066,000USD | 38,138,000USD | 25,324,000USD | -100,229,000USD | -30,896,000USD | 37,749,000USD | -61,158,000USD |
| Total Cash From Financing Activities | 328,335,000USD | 29,624,000USD | 348,000USD | 365,000USD | 14,000USD | 608,000USD | 15,000USD | 98,023,000USD |
| Issuance Of Capital Stock | 324,300,000USD | 24,250,000USD | 0USD | 0USD | 0USD | -47,001,000USD | 0USD | — |
| Change In Cash | 29,976,000USD | -78,456,000USD | 138,914,000USD | -9,031,000USD | -145,724,000USD | 98,634,000USD | 16,770,000USD | 9,095,000USD |
| Begin Period Cash Flow | 129,883,000USD | 213,293,000USD | 74,379,000USD | 83,410,000USD | 224,254,000USD | 130,483,000USD | 113,713,000USD | 99,752,000USD |
| End Period Cash Flow | 159,859,000USD | 134,837,000USD | 213,293,000USD | 74,379,000USD | 78,530,000USD | 229,117,000USD | 130,483,000USD | 108,847,000USD |
| Unclassified Financing Cash Flow | 4,035,000USD | — | — | — | — | -47,001,000USD | — | — |
| Sale Purchase Of Stock | — | -357,000USD | — | — | — | 0USD | — | — |
| Other Cashflows From Financing Activities | — | 29,624,000USD | 348,000USD | — | 14,000USD | 47,609,000USD | 15,000USD | 98,023,000USD |
| Other Cashflows From Investing Activities | — | — | 38,789,000USD | — | — | — | 38,148,000USD | -59,136,000USD |
| Unclassified Investing Cash Flow | — | — | -38,138,000USD | 1,695,000USD | 1,587,000USD | — | -37,749,000USD | 61,158,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -38,626,000USD | -72,700,000USD | -135,352,000USD | -108,501,000USD | -73,958,000USD | -35,879,000USD | -7,740,000USD |
| Depreciation | 8,356,000USD | 8,121,000USD | 6,222,000USD | 3,745,000USD | 2,132,000USD | 537,000USD | 72,000USD |
| Stock Based Compensation | 18,865,000USD | 18,126,000USD | 16,669,000USD | 11,664,000USD | 5,200,000USD | 354,000USD | 0USD |
| Other Non Cash Items | -2,204,000USD | -2,948,000USD | -3,807,000USD | 2,760,000USD | 960,000USD | 7,680,000USD | -276,000USD |
| Change To Account Receivables | -7,000,000USD | 332,000USD | 1,897,000USD | -187USD | -187,000USD | -187,000USD | -187,000USD |
| Change In Working Capital | -9,189,000USD | 91,397,000USD | 72,466,000USD | -2,134,000USD | 6,286,000USD | 4,255,000USD | 1,771,000USD |
| Total Cash From Operating Activities | -22,798,000USD | 41,996,000USD | -43,802,000USD | -92,466,000USD | -59,363,000USD | -23,053,000USD | -6,173,000USD |
| Capital Expenditures | -4,700,000USD | -3,988,000USD | -19,041,000USD | -12,911,000USD | -9,732,000USD | -3,389,000USD | -1,385,000USD |
| Free Cash Flow | -27,498,000USD | 38,008,000USD | -62,843,000USD | -105,377,000USD | -69,095,000USD | -26,442,000USD | -7,558,000USD |
| Investments | -97,133,000USD | -44,452,000USD | 20,565,000USD | -206,417,000USD | -9,653,000USD | -3,389,000USD | -1,385,000USD |
| Total Cashflows From Investing Activities | -101,833,000USD | -44,452,000USD | 88,801,000USD | -219,219,000USD | -9,653,000USD | -3,389,000USD | -1,385,000USD |
| Total Cash From Financing Activities | 30,351,000USD | 98,892,000USD | 27,492,000USD | 20,466,000USD | 377,562,000USD | 60,060,000USD | 15,000,000USD |
| Sale Purchase Of Stock | -357,000USD | -641,000USD | -116,000USD | 20,830,000USD | 377,562,000USD | -440,000USD | 0USD |
| Issuance Of Capital Stock | 24,250,000USD | 944,000USD | 0USD | 20,055,000USD | 380,750,000USD | 60,500,000USD | 14,250,000USD |
| Change In Cash | -94,280,000USD | 96,436,000USD | 72,491,000USD | -291,219,000USD | 308,546,000USD | 32,454,000USD | 7,442,000USD |
| Begin Period Cash Flow | 229,117,000USD | 132,681,000USD | 60,190,000USD | 351,409,000USD | 42,863,000USD | 9,245,000USD | 1,803,000USD |
| End Period Cash Flow | 134,837,000USD | 229,117,000USD | 132,681,000USD | 60,190,000USD | 351,409,000USD | 41,699,000USD | 9,245,000USD |
| Other Cashflows From Financing Activities | 30,351,000USD | 98,589,000USD | 27,492,000USD | 411,000USD | 139,812,000USD | 60,500,000USD | 14,250,000USD |
| Unclassified Investing Cash Flow | — | 3,988,000USD | 87,215,000USD | — | 9,731,921USD | 3,389,000USD | 1,385,000USD |
| Change To Inventory | — | — | -1,897USD | 187USD | — | — | — |
| Other Cashflows From Investing Activities | — | — | 62,000USD | -206,308USD | 79USD | — | — |
| Change To Liabilities | — | — | — | 287,000USD | 5,881,000USD | 3,435,000USD | 34,320,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -291,219,000USD | 308,546,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | -139,812,000USD | — | -8,250,000USD |
| Net Borrowings | — | — | — | — | — | — | 9,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.